|Assembly Actions - Lowercase
Senate Actions - UPPERCASE
|Jan 08, 2014||referred to health|
|May 14, 2013||referred to health|
senate Bill S5186
Archive: Last Bill Status - In Committee
- In Committee
- On Floor Calendar
- Passed Senate
- Passed Assembly
- Delivered to Governor
- Signed/Vetoed by Governor
S5186 - Details
S5186 - Summary
Creates the lupus research enhancement program; creates the lupus research enhancement fund.
S5186 - Sponsor Memo
BILL NUMBER:S5186 TITLE OF BILL: An act to amend the public health law, in relation to creating the lupus research enhancement program; and to amend the state finance law, in relation to creating the lupus research enhancement fund PURPOSE OR GENERAL IDEA OF BILL: To promote basic and clinical research programs designed to reduce or prevent suffering from Lupus, by providing funding, if available, to state academic medical institutions within the state currently conducting or having an interest in conducting basic and clinical, social, translational, technological, epidemiological, and behavioral research on Lupus. SUMMARY OF SPECIFIC PROVISIONS: The Commissioner of Health shall establish within the department a Lupus research enhancement program through which the department shall make grants to state academic medical institutions within the state currently conducting or having an interest in conducting basic and clinical, social, translational, technological epidemiological and behavioral research on Lupus. The Commissioner shall establish a multidisciplinary Lupus research advisory council to monitor progress and make granting recommendations to the department. The council shall
S5186 - Bill Text download pdf
S T A T E O F N E W Y O R K ________________________________________________________________________ 5186 2013-2014 Regular Sessions I N S E N A T E May 14, 2013 ___________ Introduced by Sen. SAVINO -- read twice and ordered printed, and when printed to be committed to the Committee on Health AN ACT to amend the public health law, in relation to creating the lupus research enhancement program; and to amend the state finance law, in relation to creating the lupus research enhancement fund THE PEOPLE OF THE STATE OF NEW YORK, REPRESENTED IN SENATE AND ASSEM- BLY, DO ENACT AS FOLLOWS: Section 1. Article 2 of the public health law is amended by adding a new title 4-A to read as follows: TITLE IV-A LUPUS RESEARCH ENHANCEMENT ACT SECTION 256. SHORT TITLE. 256-A. LEGISLATIVE INTENT. 256-B. DEFINITION. 256-C. LUPUS RESEARCH ENHANCEMENT PROGRAM. 256-D. LUPUS RESEARCH ADVISORY COUNCIL. 256-E. LUPUS RESEARCH ENHANCEMENT FUND. S 256. SHORT TITLE. THIS TITLE SHALL BE KNOWN AND MAY BE CITED AS THE "LUPUS RESEARCH ENHANCEMENT ACT". S 256-A. LEGISLATIVE INTENT. 1. THE LEGISLATURE HEREBY FINDS THE FOLLOWING: (A) LUPUS IS A SERIOUS, COMPLEX, DEBILITATING AUTOIMMUNE DISEASE THAT CAN CAUSE INFLAMMATION AND TISSUE DAMAGE TO VIRTUALLY ANY ORGAN SYSTEM IN THE BODY, INCLUDING THE SKIN, JOINTS, OTHER CONNECTIVE TISSUE, BLOOD AND BLOOD VESSELS, HEART, LUNGS, KIDNEY, AND BRAIN. (B) THE LUPUS FOUNDATION OF AMERICA, INC. ESTIMATES THAT APPROXIMATELY 1.5 TO TWO MILLION AMERICANS LIVE WITH SOME FORM OF LUPUS; LUPUS AFFECTS WOMEN NINE TIMES MORE OFTEN THAN MEN AND EIGHTY PERCENT OF NEWLY DIAG- NOSED CASES OF LUPUS DEVELOP AMONG WOMEN OF CHILDBEARING AGE. EXPLANATION--Matter in ITALICS (underscored) is new; matter in brackets [ ] is old law to be omitted. LBD02045-01-3
Open Legislation comments facilitate discussion of New York State legislation. All comments are subject to moderation. Comments deemed off-topic, commercial, campaign-related, self-promotional; or that contain profanity or hate speech; or that link to sites outside of the nysenate.gov domain are not permitted, and will not be published. Comment moderation is generally performed Monday through Friday.
By contributing or voting you agree to the Terms of Participation and verify you are over 13.